NCT02583126

Brief Summary

The purpose of this study is to determine whether a modified and resource-oriented form of Guided Imagery and Music (GIM) is effective in reducing side effects of chemotherapy in teenagers with cancer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Aug 2014

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 3, 2015

Completed
9 months until next milestone

First Posted

Study publicly available on registry

October 22, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

December 2, 2015

Status Verified

November 1, 2015

Enrollment Period

2.8 years

First QC Date

February 3, 2015

Last Update Submit

November 30, 2015

Conditions

Keywords

Teenagermoderate and/or highly emetogenic chemotherapy

Outcome Measures

Primary Outcomes (1)

  • Duration (minutes) of Acute Nausea

    Self-reported duration og nausea in minutes during the first 32 hours after onset of chemotherapy

    Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study

Secondary Outcomes (14)

  • Intensity of Acute Nausea as measured by the Visual Analogue Scale

    Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study

  • Distress regarding Acute Nausea as measured by the Visual Analogue Scale

    Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study

  • Amount (mg/m2) of Nausea Reducing Medicine Consumed

    During admission (an expected average of 3 days) and the first three days after discharge regarding 5th cycle of chemotherapy after enrolment in study

  • Multiple Acute Side Effects of Chemotherapy as measured by the Memorial Symptom Assessment Scale

    Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study

  • Numbers of Acute Vomiting

    Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study

  • +9 more secondary outcomes

Study Arms (2)

Music Group

EXPERIMENTAL

Prescribed medical/chemotherapy treatment plus standard care + Guided Imagery and Music

Behavioral: Guided Imagery and Music

Control Group

NO INTERVENTION

Prescribed medical/chemotherapy treatment plus standard care

Interventions

Modified and resource-oriented form of the Bonny Method of Guided Imagery and Music (BM-GIM)

Also known as: Music and imagery, music therapy, active music listening
Music Group

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Teenagers at the ages 12-17
  • Four or five (dependent on their overall plan of medical treatment) consecutive courses of chemotherapy administrated at the involved child cancer units and (administered) over a period of minimum 24 hours incl. hydration with assumed moderate to severe nausea and vomiting.
  • The specific type of chemotherapy may vary across the four/five consecutive courses but shall include one of the following moderate and/or highly emetogenic types of chemotherapy:
  • Moderate emetogenic chemotherapy:
  • Carboplatin
  • Cyclophosphamide \<1500 mg/m2
  • Cytarabine \>1 g/m2
  • Daunorubicin
  • Doxorubicin
  • Epirubicin
  • Idarubicin
  • Ifosfamide
  • Mitoxantrone
  • Methotrexate \>1000 mg/m2
  • Highly emetogenic chemotherapy:
  • +8 more criteria

You may not qualify if:

  • Previous and/or acute psychiatric diagnosis
  • Cognitive and mental deficits or impaired functioning

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus, 8200, Denmark

RECRUITING

Related Publications (1)

  • Bradt J, Dileo C, Myers-Coffman K, Biondo J. Music interventions for improving psychological and physical outcomes in people with cancer. Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD006911. doi: 10.1002/14651858.CD006911.pub4.

MeSH Terms

Conditions

Neoplasms

Interventions

Imagery, PsychotherapyMusic Therapy

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and ActivitiesSensory Art TherapiesRehabilitationAftercareContinuity of Patient CarePatient Care

Study Officials

  • Ilan Sanfi, PhD

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ilan Sanfi, PhD

CONTACT

Stine Camilla Ærø, BA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Music therapist, PhD

Study Record Dates

First Submitted

February 3, 2015

First Posted

October 22, 2015

Study Start

August 1, 2014

Primary Completion

June 1, 2017

Study Completion

December 1, 2017

Last Updated

December 2, 2015

Record last verified: 2015-11

Locations